Status:
COMPLETED
Obesity and Mortality of Critically Ill Patients With COVID-19
Lead Sponsor:
Central Hospital, Nancy, France
Conditions:
COVID
Severe Acute Respiratory Syndrome
Eligibility:
All Genders
18+ years
Brief Summary
Disproportionate impact of COVID-19 in patients with obesity is now well established. Obesity is associated with severe forms of COVID-19 and may be a risk factor of intensive care unit (ICU) admissi...
Detailed Description
The investigators aim to report ICU mortality for patients according to BMI category and to describe the detailed ICU clinical course of illness : * Risk factors for ICU mortality : age, sex, baselin...
Eligibility Criteria
Inclusion
- Adult patients with COVID-19 pneumonia admitted to ICUs between February 27th and April 18th 2020.
- Infection confirmed by reverse transcriptase polymerase chain reaction assay or radiologically by chest computed tomography scan
Exclusion
- No weight or height measurement available in the medical files
Key Trial Info
Start Date :
May 12 2020
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
May 26 2020
Estimated Enrollment :
250 Patients enrolled
Trial Details
Trial ID
NCT04425213
Start Date
May 12 2020
End Date
May 26 2020
Last Update
June 16 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Centre hospitalo-universitaire régional de Nancy
Vandœuvre-lès-Nancy, France, 54511